Graduate Students

57. Suresh Vutla (M.Sc. 09/17- 10/19)......................................................................................................................Intellisyn, QC

56. N. D. Prasad Atmuri (Ph.D. 01/15 - 06/19,  ).................................................................................................PDF w/Prof. Marco Ciufolini

55. Fatemeh Mohammadpourmir (Ph.D. 01/15 - 05/19, Azaglycinyl peptides).................................Scientist, Apotex, ON

54. Antoine Douchez (Ph.D. 01/14 – 09/18, Benzatriazepinones)............................................................PDF w/Prof. D. Perrin, UBC

53. Ramesh Chingle (Ph.D. 01/13 – 08/18, Azopeptides) ..............................................................................PDF w/Prof. T. Burke Jr.  Ntl. Inst. Health / National Cancer                                                                                                                                     Institute, USA

52. Kelvine Chignen Possi (M.Sc. 05/14 – 12/17, Azapeptide CD36 modulators)..............................Research Asst. U. Montréal

51. Olivier Van der Poorten (Ph.D. exchange Vrije U. Brussel 07–10/17, Opioid ligands).............Ph.D. student VUB

50. Martina De Pascale (Ph.D. exchange U. Caen Normandie 01–08/17, Smac mimics)..............Ph.D. student UCN  

49. Jade Perrichon (M.Sc. exchange UMPC 01/16 – 05/16, Urotensin Receptor Ligands)...........M.Sc. student UMPC

48. Mbyas Saroukou (M.Sc. 09/13 – 03/16, Pyrroles)......................................................................................Quality control assessor, Plats du Chef Inc., Montreal, QC

47. Julien Dufour (M.Sc. 09/09 – 09/16, Pyrrolodiazepinones).................................................................Res. Chemist Asplas Pharma Inc. Montreal, QC

46. Aurélie Dörr (M.Sc., 01/04 - 08/07; Ph.D., 09/07 -  Medical Leave, Pyrrolo-Alanines)........------------------

45. Martin Strack (Ph.D. exc. Ruhr-U. Bochum 06–11/15, Cyclic peptides)...........................................Scientist, Mercachem, Nijmegen, NL

44. Stéphane Turcotte (Ph.D. 09/09 – 08/15, Aminosulfonyldiamides)...............................................Scientist, IntelliSyn Inc., Montreal, QC

43. Miriem Boukanoun (M.Sc. 09/11 – 07/15, Azabicycloalkanones)........................................................Ph.D. student, U. Djillali Liabes, Sidi Bel Abbès, AL

42. Jennifer Rodon Fores (M.Sc. exc. UMPC 01/15 – 09/15, FP modulators)........................................Ph.D. student, Charles Sadron Inst., Strasbourg, FR    

41. Ali Munaim Yousif (Ph.D. exchange U. Naples 10/14 – 03/15 UT ligands)......................................PDF, U. Texas, Dallas, TX, USA

40. Lylia Dif-Yaïche (M.Sc. exchange UMPC 02/14 – 11/14, Aminosulfurylpeptides).......................M.Sc. UMPC, Paris, FR

39. Francesco Merlino (Ph.D. exchange U. Naples 01/13–12/13 UT ligands).........................................PDF, U. Naples, IT

38. Carine Bourguet (Ph.D., 01/04 – 11/12, Prostaglandin Antagonists)................................................Scientist IntelliSyn Inc. Montreal, QC

37. Tanya Godina (M.Sc., 01/07 – Med. Leave, Cyclic peptides)...................................................................Assoc., RBC Dominion Sec. Inc., Montréal, QC

36. Caroline Proulx (PhD, 09/07-10/12, Azapeptides).......................................................................................Asst. Prof. Chem., N. Carolina State U., Raleigh, NC, USA

35. Robert Hopewell (M.Sc. 09/09 - Amino Cyclic Ureas)..............................................................................Hospital Radiology Technician, Montréal, QC

34. Kim Beauregard (M.Sc. 09/09 – 02/12 IL1 Modulators)...........................................................................Laboratory Director of Lalema Inc., Montreal, QC

33. Tshibaka Tshitundu (M.Sc., 09/07 – 08/11 Bipyrrole Chemistry)........................................................Technician U. Montreal, Montreal, QC

32. Nicolas Genest (M.Sc., 05/05 – 09/10 Homoallylic Ketones)................................................................Scientist, L'Oréal, Montreal, QC

31. Wajih Ben Tahar (M.Sc., 09/05 – 09/09 Fluorescent Peptides)..........................................................Res. Asst., Radiopharmaceutical Quality Assurance and 

                                                                                                                             Manufacturing, Montréal, QC

30. Philippe Deaudelin (M.Sc., 06/06 - 02/09, Pyrrole Libraries................................................................Scientist Galderma, Baie d'Urfé, QC

29. Hassan Iden (M.Sc, 09/04 - 04/08, Pyrrolodiazepinones)....................................................................PDF, U. Laval, Quebec City, QC

28. Benoît Jolicoeur (M.Sc., 01/04 - 06/07, Prodigiosins)..............................................................................Chemist, General Dynamics Ordnance and Tactical Systems,

                                                                                                                              Montréal, QC

27. Zohreh Sajjadi (M.Sc., 09/03 - 06/07, Azetidines)......................................................................................Medicinal/Organic Chemist, AMRI, Albany, NY, USA

26. Christophe Pardin (Ph.D., co-dir. w/J. Keillor, 05/03 - 05/07, TGase Inhibitors)........................Prof. de l'Outaouais College, Ottawa, ON

25. Charles Banville (M.Sc., 09/02 - 07/06, Pyrrolizidinones).......................................................................Scientist, L'Oréal, Montreal, QC

24. Simon Suprenant (M.Sc., 09/03 - 01/06, Azabicycloalkanes)................................................................Scientist, Boehringer Ingelheim, Laval, QC

23. Yann Brouillette (M.Sc., 09/03 - 09/05, Pyrrole Libraries)......................................................................Prof. Chem. Dawson College, Montréal, QC

22. Fabrice Galaud (M.Sc., 09/01- 08/05, Amino Lactams)..............................................................................Res. Asst., IRIC, U. Montréal, Montréal, QC

21. Guillaume Jeannotte (M.Sc., 09/01- 09/04, Pyrrolo-Prolines)...............................................................Scientist, L'Oréal, Montreal, QC

20. James Dettwiler (M.Sc., 01/01 - 08/04, Aureobasidin mimics)..............................................................Scientific Advisor, Etat du Canton de Vaud, CH

19. Jérome Cluzeau (Ph.D. 09/98 - 08/04, CGRP Peptide Mimics)..............................................................Sr. Scientist, Lek Pharma. Menges, Slovenia

18. Felix-A. Marcotte (M.Sc. 09/01-08/04, NSERC Sch., Aminopyrroles)..................................................Prof., St. Jerome College, St Jerome, QC

17. Catherine Girard (M.Sc. 05/01-09/03, NSERC Scholar, Hdac Inhibitors)............................................Med. School, Montréal, Montreal, QC

16. Evelyn Dietrich (M.Sc. 08/00- FCAR Scholar 00-02, pyrrolizidinones)..............................................Sr. Scientist, Repare Therapeutics, Montreal, QC

15. Laurent Bélec (M.Sc. 09/95 - 12/96, Ph.D. 01/97 - 11/02, 5-t-BuPro Oxytocin Mimics)...........Assoc. Director, Thrasos Therapeutics, Montreal, QC

14. Kenza Daiiri (M.Sc. 05/98 - 03/02, Protease mimicry)................................................................................Corp. Partnerships Exec., Rethink Mental Illness, London, UK

13. Liliane Halab (Ph.D. 05/96 - 03/02, NSERC Sch., Type VI turns).............................................................Prof. Marianopolis College. Westmount, QC.

12. Simon Roy (M.Sc. 06/97 - 05/01; FCAR Sch., Gramicidin S Mimics)......................................................Scientist, Methylgene Inc., Montréal. QC

11. Eryk Thouin (M.Sc., NSERC Sch.; Res. Asst. 07/01- 04/04, Enz. inhibitors)........................................Scientist, BioAxone, Montreal, QC

10. Zhe Feng (M.Sc. 09/97 - 09/00, Indolizidinone Amino Acids)................................................................Scientist, Novartis Res. Corp., Summit, NY, USA

9.   Lan Wei (M.Sc. 08/97 - 06/00, AMPA-like Isoxazole Amino Acids)....................................................Scientist, Merck, Rahway, NJ, USA

8.   Francis Gosselin (M.Sc. 09/95 - 12/96, Ph.D. 01/97 - 01/00, NSERC scholar, Heterocyclic Peptides)........Director, Head of Process Chemistry, Genentech,

                                                                                                                               San Francisco, CA, USA

7.   Eric Beausoleil (M.Sc. 05/92 - 05/94, Ph.D. 05/94 - 09/99, Alkylprolines).....................................Director Business Development Europe, SiliCycle Inc., Paris,

                                                                                                                                France.

6.   Dany Rondeau (M.Sc. 06/97 - 12/98, Kainoids)..............................................................................................Professor, Andre-Grasset College, Montreal, QC

5.   Henry-Georges Lombart (Ph.D. 09/92 - 09/97, Indolizidinones).........................................................Project Mgr., Chem. AsisChem, Boston, MA, USA

4.   Patrice Gill (M.Sc. 01/94 - 05/97, Kainoids)........................................................................................................Scientist, Bristol Myers Squibb, Princeton, New Jersey, USA

3.   Trang Pham (M.Sc. 05/92 - 05/93; Ph.D. 05/93 - 02/97, Bio-Méga Scholar, Enantioselective hydrogenation).......PDF w/ Prof. R. Noyori, U. Nagoya,                                                                                                                                         presently QA Auditor for Quintiles AB, Uppsala, Sweden.

2.   Benoit L'Archevèque (M.Sc. 09/93 - 09/95, NSERC Scholar, 5-t-BuPro7-OT)................................Marketing Intelligence Analyst, Novartis, Montreal, QC

1.   Mohamed Atfani (Ph.D. 01/93 - 05/94 Isoxazole Amino Acids)...............................................................Research Asst. U. Montréal, Montréal QC.

 

 

Post-doctoral fellows

38. Ragnhild G. Ohm (01/17 – 08/18, CD36 modulators)...............................................Process chemist, Lundbeck pharm, Denmark

37. Ahsanullah (04/15 – 10/16 CD36 peptide mimic ligands) ....................................Scientist Mperia Therapeutics Inc., Montreal,QC

36. Mariam Traore (05/13 – 04/16 Aza-Arginine Peptides).........................................Scientist IntelliSyn Inc. Montreal, QC

35. Jinqiang Zhang (04/13 – 01/16 Aza-Lysine Peptides)..............................................Assistant Professor Chongqing U., China

34. Yessica Garcia-Romas (10/10 – 10/15, CD36 Ligands)..............................................Scientist NuChem Pharma Montreal, QC

33. Carine Bourguet (11/12 – 11/13 Prostaglandin Modulators)...................................Scientist IntelliSyn Inc. Montreal, QC

32. Stefan Soderman (09/13 – 10/14 Thiosemicarbazides)...........................................Chemist I Process R&D, Apotex Inc. Mississauga, ON

31. Doan Ngoc Duc (06/12 – 08/14 Amino Cyclic Ureas).................................................Post-Doctoral Fellow, MIT, Cambridge, MA, USA

30. Tarek Kassem (11/06 – 05/12, PVA-PEG Chemistry).................................................. Founder Izi-Chem Inc., Montréal, QC

29. Daniel St-Cyr (08/08–02/12, Hydroxy Amino Lactam)........................................... Tech., Inst. Res. Immunol. Cancer, Montréal, QC

28. Nicolas Boutard (05/07 – 04/11, Amino-Lactams).....................................................Medicinal Chemist, D3 - Drug Discovery Dev. Genova, Italy

27. David Sabatino (04/07 – 07/10, Azapeptides)..............................................................Asst. Professor Biochem., Seaton Hall U., S. Orange, NJ, USA.

26. Luisa Ronga (03/08 – 06/09, Lactam Mimics).............................................................Asst. Prof. Chem., U. de Pau et des Pays de l’Adour, Pau, FR

25. Gil Fridkin (08/03 - 12/08, Deazapurines).......................................................................Scientist, Israel Inst. for Biol. Research, Ness-Ziona, Israel

24. Wang Chen (11/07 - 10/08, IL1 Ligands)...........................................................................Process Chemist, Thesis Chem. Inc., Cambridge, ON

23. Andrew Jamieson (01/07 - 08/08, Amino Lactam Mimics)..................................Senior Lecturer, Glasgow University, UK

22. Teresa Lama (09/05 - 02/07, Hydroxyethylene Isosteres)...................................Scientist, Mimetogen Inc., Montreal, QC

21. Louis Watanabe (05/06 - 01/07, Amino Lactams)......................................................Director, Watanabe Chem. Ind., Hiroshima City, Japan

20. Susan Seaman (01/05 - 07/06, Quinolizidinone Mimics)......................................Editorial Assistant for Organic Letters, USA

19. John Blankenship (06/03 - 05/06, Sheet Mimics).....................................................Senior Scientist, Aptevo Therapeutics, Seattle, USA

18. Mandar Bodas (10/04 - 03/06, Amino Lactams).........................................................Solution Consultant for Elsevier’s life science products

17. Ramana Rao (03/04 - 03/06, Pyrrolizidinones)...........................................................Principal research scientist, GVK Biosciences, India

16. Juntao Luo (09/04 - 09/05, PVA-PEG Resin).................................................................Asst. Prof. Pharmacol. Upstate Medical U., SUNY Syracuse, USA

15. Damien Boeglin (01/04 - 08/05, Aza-Peptides)...........................................................Alsachim Bioparc, Graffenstaden, France

14. Martin Gagnon (co-dir. w/U. Saragovi, 09/03 - 03/05, GD2 Ligands)..............Scientist, Chlorion Pharma, Quebec, QC

13. Karl Hansford (03/03 - 05/05, Cytokine Ligands)........................................................Scientist, Boron Molecular, Melbourne Australia

12. Ramesh Kaul (05/02 - 03/05, GPCR Ligands)..................................................................Scientist, NeuroMed, Vancouver, BC

11. Rosa Melendez (03/01 - 11/03, FCAR Fellow, Azapeptides)......................................Scientist, Goodmans LLP, Toronto, ON

10. Wim de Borggraeve (03/03 - 08/03, Pyrrolizidinones)............................................Assistant Professor, Katholieke U. Leuven, Belgium

9.   Frederik Rombouts (10/02 - 07/03, Deazapurines)...................................................Scientist, Jensen Pharma, Belgium

8.   Mohamed Atfani (06/00 - 01/01, Glu-Receptor Ligands).......................................Research Asst. U. Montreal, Montreal, QC

7.   Hovsep Avedissian (06/00 - 03/01, Rho- Kinase Ligands)...................................PDF w/ Pr. Ganesan, Southampton U., UK

6.   Jo van Betsbrugge (09/97 - 05/00, Azasugar Mimics)............................................Founder BioQuadrant Pharm, Inc. Laval, QC

5.   Felix Polyak (03/97 - 07/99, FP Ligands)........................................................................Chief Operating Officer, Aluron Biopharma Inc. Montreal, QC

4.   Martin Swarbrick (Glaxo Fellow, 01/98 - 06/99, Alkylpipecolates)..................Scientist, Glaxo, Stevenage, UK

3.   Mostafa Hatam (10/97 - 06/99, Azasugar Synthesis).............................................Scientist, Aapptec Inc., USA

2.   Raman Sharma (10/93 - 07/95, beta-Alkylprolines).................................................PDF w/ Professor S. Hanessian, U. Montréal, QC

1.   Houda Haj Ibrahim (10/91 - 08/93, Alkylprolines)......................................................Research Scientist, Separation Technologies, USA